VItamin D Metabolism in SEnescent Cardiac Surgery Patients
VISE
Vitamin D Metabolism in Senescent Cardiac Surgery Patients
1 other identifier
observational
75
1 country
1
Brief Summary
Advanced age is associated with an increase in postoperative morbidity and mortality in cardiac surgery patients. In detail, compared with younger patients those aged 75 years and older have significantly higher rates of in-hospital mortality, cerebrovascular events, pneumonia, and dialysis. In addition, older cardiac surgery patients have longer mechanical ventilation times. Vitamin D exerts several beneficial effects on the cardiovascular system. Moreover, it has immuno-modulatory and anti-inflammatory properties. The hormonal form of vitamin D, 1,25-dihydroxyvitamin D, is an independent predictor of mid-term mortality in cardiac transplant recipients. 1,25-dihydroxyvitamin D also predicts mid-term and long-term mortality in patients with a high risk for cardiovascular disease. Mild renal impairment, insufficient vitamin D levels, and secondary hyperparathyroidism are common in frail elderly individuals. The present study aimed to investigate whether cardiac surgery exerts age-dependent effects on calciotropic hormones, components of the immune system, and inflammatory processes.It is hypothesized that (i) baseline 1,25-dihydroxyvitamin D levels are lower in patients \<= 75 years of age compared to younger patients, (ii) cardiac surgery results in a transient decrease in circulating 1,25-dihydroxyvitamin D, and (iii) that the decrease in 1,25-dihydroxyvitamin D is probably more pronounced in older than in younger cardiac surgery patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2011
CompletedFirst Submitted
Initial submission to the registry
June 20, 2011
CompletedFirst Posted
Study publicly available on registry
June 22, 2011
CompletedResults Posted
Study results publicly available
January 30, 2014
CompletedJanuary 30, 2014
December 1, 2013
1.4 years
June 20, 2011
December 11, 2013
December 11, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Peri- and Postoperative Time Course of Circulating 1,25-dihydroxyvitamin D in the First Postoperative Month in Cardiac Surgery Patients
change from baseline within 1 month after cardiac surgery
Study Arms (2)
Group 1
cardiac surgery patients age 65 years and less
Group 2
cardiac surgery patients aged 75 years and over
Eligibility Criteria
elective cardiac surgery patients receiving isolated coronary artery bypass grafting or combined coronary artery bypass grafting and heart valve surgery
You may qualify if:
- age: \<= 65 years and \>= 75 years
- first elective cardiac surgery (bypass or combined bypass and heart valve surgery)
- written informed consent
You may not qualify if:
- emergency cardiac intervention
- primary hyperparathyreoidism
- primary and secondary hypoparathyreoidism
- daily vitamin D supplementation \> 10 micrograms
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Heart Center North Rhine-Westphalia
Bad Oeynhausen, North Rhine-Westphalia, 32545, Germany
Related Publications (1)
Borgermann J, Lazouski K, Kuhn J, Dreier J, Schmidt M, Gilis-Januszewski T, Knabbe C, Gummert JF, Zittermann A. 1,25-Dihydroxyvitamin D fluctuations in cardiac surgery are related to age and clinical outcome*. Crit Care Med. 2012 Jul;40(7):2073-81. doi: 10.1097/CCM.0b013e31824e8c42.
PMID: 22584760RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Armin Zittermann
- Organization
- Heart and Diabetes Center North Rhine-Westphalia, Germany
Study Officials
- PRINCIPAL INVESTIGATOR
Jochen Börgermann, MD
Heart Center NRW, Ruhr University Bochum, 32545 Bad Oeynhausen, Germany
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 20, 2011
First Posted
June 22, 2011
Study Start
September 1, 2009
Primary Completion
February 1, 2011
Study Completion
May 1, 2011
Last Updated
January 30, 2014
Results First Posted
January 30, 2014
Record last verified: 2013-12